Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An immunohistopathologic study in cutaneous necrotizing vasculitis.

I Bielsa1, J M Carrascosa, G Hausmann

  • 1Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Journal of Cutaneous Pathology
|March 23, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of the Influence of Sex in 507 Patients With Moderate-to-Severe Atopic Dermatitis. Spanish Atopic Dermatitis Registry (BIOBADATOP).

Actas dermo-sifiliograficas·2026
Same author

Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology.

Actas dermo-sifiliograficas·2025
Same author

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

[Translated article] Expert Recommendations on Topical Therapy for Psoriasis from the Spanish Psoriasis Working Group (GPS).

Actas dermo-sifiliograficas·2025
Same author

[Translated article] Updated Perspective from the Spanish Psoriasis Working Group (GPS) on Biosimilar Drug Use in Moderate-to-Severe Psoriasis.

Actas dermo-sifiliograficas·2025
Same author

Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study.

Actas dermo-sifiliograficas·2025

The inflammatory infiltrate in cutaneous necrotizing vasculitis (CNV) changes over time, with polymorphonuclear leukocytes decreasing and macrophages increasing. This study highlights the dynamic immunophenotypic changes in CNV.

Area of Science:

  • Immunopathology
  • Dermatology
  • Inflammation Research

Background:

  • Cutaneous necrotizing vasculitis (CNV) is characterized by inflammation of skin blood vessels.
  • Understanding the temporal dynamics of cellular infiltrate and adhesion molecules is crucial for CNV pathogenesis.
  • Previous studies have not fully elucidated the time-dependent changes in CNV immunophenotype.

Purpose of the Study:

  • To investigate the temporal evolution of inflammatory cell infiltrate and adhesion molecule expression in CNV.
  • To determine if distinct immunophenotypic patterns emerge at different time points in CNV lesions.
  • To correlate these changes with the progression of the vasculitic process.

Main Methods:

  • Immunohistopathologic study using avidin-biotin-streptavidin peroxidase technique.

Related Experiment Videos

  • Sequential skin biopsy specimens (0-120 hours) from seven CNV patients.
  • Monoclonal antibodies for inflammatory cells (T lymphocytes, PMNs, macrophages, dendritic cells) and adhesion molecules (E-selectin, ICAM-1, VCAM-1, LFA-1, VLA-4), plus HECA-450 for CLA.
  • Main Results:

    • Polymorphonuclear leukocytes predominated early, decreasing significantly over time (p=0.0001).
    • Macrophages showed a time-dependent increase (p=0.0003), becoming more prominent.
    • E-selectin (ELAM-1) expression decreased with lesion age (p=0.0033), and CLA expression also declined (p=0.0001).

    Conclusions:

    • CNV exhibits a unique, time-dependent histopathologic pattern.
    • The inflammatory infiltrate dynamically shifts, with a decrease in polymorphonuclear cells and an increase in macrophages.
    • These temporal immunophenotypic changes are key to understanding CNV progression.